PAVmed receives additional 180-day Nasdaq extension to meet $1 bid price rule

PAVmed Inc.

Nasdaq granted PAVmed until December 26, 2023 to regain $1 minimum bid price compliance.
Company failed to meet compliance by original June 27, 2023 deadline.
To regain compliance, common stock must close at $1+ for 10 consecutive business days.
PAVmed intends to consider all available options to address the bid price deficiency.
Listing of common stock (PAVM) and Series Z warrants (PAVMZ) remains uninterrupted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.